Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Oden6570on Feb 07, 2022 8:59am
498 Views
Post# 34404108

RE:RE:RE:Vaccine Timeline

RE:RE:RE:Vaccine Timeline
prophetoffacts wrote: Right now COVID is about variants and the ability to more rapidly respond to such variants. TLT has a path and given what is known about inactivated vaccines already the biggest durdles may be behind the company.

Sunvalley wrote:
I would imagine with the initial validation out of the way, events on the Covid front should now accelerate fairly rapidly given the worldwide panic the virus has caused. They should also now be among the first in line for further Government grants and support.




If you have followed the progress on this vaccine vertical you will recall TLD1433 has proven highly effective in killing influenza viruses. Just think of the world wide implications opportunities with just the flu alone. And yearly a search for an effective flu vaccine is conducted to find one with a high rate of efficacy. I would say 99.99 % meets the criteria. I can not imagine any serious investors selling TLT shares prior to aquisition regardless of sp.
<< Previous
Bullboard Posts
Next >>